AST/ALT ratio (De Ritis): What it reveals about your liver and longevity

Every year millions of people receive their blood test results, check whether AST and ALT fall within the reference range, and breathe a sigh of relief. But almost no one looks at the ratio between these two enzymes — a value that can sometimes be more informative than either number alone when it is interpreted in context.

If your broader liver panel shows normal ALT with high GGT, read that pattern separately from the AST/ALT ratio because the next questions are different. The same is true when AST is high with normal ALT, where muscle, exercise, hemolysis, alcohol pattern, and liver context need to be separated before interpreting the ratio.

If you have ever received “normal” transaminase results and assumed everything was fine, you might be missing an important signal. The AST/ALT ratio, known as the De Ritis ratio, is a subtle indicator that can flag liver, muscle, alcohol, and metabolic patterns and has been associated with long-term risk in cohort studies.

What you will learn:

• What AST and ALT are and when their ratio adds context beyond individual values
• How to interpret the De Ritis ratio with reference tables
• The observed association between the AST/ALT ratio and long-term risk
• Actionable strategies to optimize your liver values

Quick answer

The AST/ALT ratio, or De Ritis ratio, is AST divided by ALT. A ratio near 1 is often a balanced pattern; <1 often fits metabolic fatty liver or early hepatocellular injury, while >2 plus elevated GGT can support alcohol-related injury or advanced liver disease. The ratio is a clue, not a diagnosis: interpret it with absolute AST and ALT, alkaline phosphatase, bilirubin, albumin, platelets, symptoms, medications, hemolysis, and recent intense exercise.

Key facts

• AST/ALT ratio -> role -> pattern recognition: the ratio adds context to enzyme values, but it does not replace diagnosis.
• ALT -> specificity -> liver-weighted signal: ALT elevations are generally more specific for hepatocellular injury.
• AST -> distribution -> liver, muscle, heart: exercise or muscle injury can raise AST and distort the ratio.
• High ratio -> signal -> observational risk: CKD and ICU studies link higher ratios with mortality, but they do not prove causality or create home cutoffs.

---

What Are AST and ALT?

AST (aspartate aminotransferase) and ALT (alanine aminotransferase) are two enzymes found in liver cells that play a key role in amino acid metabolism. When liver cells are damaged, these enzymes leak into the bloodstream — which is why their concentrations are used as markers of liver injury.

Quick definition: The AST/ALT ratio (or De Ritis ratio) is the quotient of serum aspartate aminotransferase to alanine aminotransferase levels. It can help pattern-match liver, muscle, alcohol, and advanced-disease signals, but it does not diagnose severity by itself.

The Key Difference Between the Two Enzymes

Here is the critical point: ALT is more liver-weighted, while AST is also present in the heart, skeletal muscle, kidneys, red blood cells, and brain. This different tissue distribution is what makes their ratio informative, and also why non-liver sources can mislead it.

• ALT: concentrated mainly in the liver, it is usually more specific for hepatocellular injury than AST
• AST: distributed across multiple tissues, its elevation can point to problems beyond the liver

When your doctor orders “liver enzymes,” they are measuring exactly these two enzymes. But stopping at the absolute values is like reading only half the story.

---

The History of the De Ritis Ratio

The ratio is named after Italian physician Fernando De Ritis, who in 1957 published the first systematic description of the relationship between AST and ALT in liver disease. His pioneering work showed that it was not just the magnitude of the elevation that mattered, but the relative proportion of the two enzymes.

More than 60 years after its discovery, the De Ritis ratio remains one of the most widely used diagnostic tools in hepatology — a rare example of a test that has stood the test of time in modern medicine.

---

How to Interpret the AST/ALT Ratio

In healthy liver cells, the proportion of AST to ALT is roughly 2.5:1. However, because AST is cleared from the blood about twice as fast as ALT (half-life of 18 hours versus 36 hours), serum levels in healthy individuals are approximately equal, producing a ratio close to 1.

Interpretation Table

AST/ALT Ratio	Interpretation	Possible Causes
0.7 – 1.2	Often balanced	No single-cause signal by ratio alone
< 1	ALT predominance	Steatotic liver disease (MASLD), acute viral hepatitis
> 1	AST predominance	Cirrhosis, advanced chronic liver disease
> 2	Strong AST predominance	Alcoholic liver disease
> 5	Likely extra-hepatic cause	Muscle, cardiac, or bone injury

What a Low Ratio (< 1) Means

A ratio below 1, where ALT exceeds AST, is the typical pattern of metabolic dysfunction-associated steatotic liver disease (MASLD, the new nomenclature adopted in 2023 to replace NAFLD) — a condition that now affects roughly 30% of the global adult population, according to the latest international consensus. In this scenario, the damage is predominantly hepatic and in its early stages.

What a High Ratio (> 1) Means

When AST exceeds ALT, the picture becomes more complex. A ratio above 2 can support alcohol-related liver damage or advanced liver disease, especially when accompanied by elevated GGT (gamma-glutamyl transferase). A ratio that rises above 1 in someone with steatotic liver disease may raise concern for advanced fibrosis, but it still needs absolute enzyme values, platelet count, fibrosis scores, imaging, and clinical context.

Watch Out for False Positives

Several situations can skew the ratio without indicating an actual liver problem:

• Intense or unfamiliar exercise: weightlifting can raise AST, ALT, CK, LDH, and myoglobin for at least several days; AST can rise more than ALT and temporarily distort the ratio
• Muscle injury: any muscle trauma preferentially elevates AST
• Medications: statins, acetaminophen (paracetamol), and certain antibiotics can shift the ratio

---

AST and ALT Target Ranges for Prevention

Standard laboratory reference ranges are broad and designed to detect overt disease. Prevention-oriented interpretation pays attention to lower-normal values and trends, but there is no single universal “optimal” cutoff for every age, sex, and clinical context.

Standard ranges vs prevention targets

Enzyme	Typical Lab Reference Range	Conservative tracking zone to discuss
AST	6–40 U/L	Lower-normal when muscle injury and frailty are not present
ALT	7–56 U/L	Lower-normal, especially when metabolic risk is low
AST/ALT Ratio	0.7–1.4	Near 1, unless context explains otherwise

Lower-normal AST and ALT often track with better metabolic health, lower liver-fat burden, and lower cardiovascular risk, but very low values in older or frail adults can also reflect low muscle mass or illness. Treat these as tracking zones, not universal cutoffs.

Why Lab Reference Ranges Are Misleading

Reference ranges are calculated from the general population — which includes a significant percentage of people with subclinical fatty liver, excess weight, and metabolic syndrome. This means the laboratory “normal” already encompasses sub-optimal values.

---

AST/ALT Ratio and Longevity: What the Research Says

The connection between the AST/ALT ratio and long-term outcomes is mostly observational. New 2025 studies add useful risk-stratification data, but the ratio should still be read as a context marker rather than a standalone predictor.

The ratio is associated with all-cause mortality

A 2022 community cohort in the Journal of Clinical Laboratory Analysis found that a higher AST/ALT ratio was associated with all-cause mortality and incident cancer among adults aged 40 and older. This is an observational risk signal, not proof that the ratio itself causes disease.

A 2025 Scientific Reports study drawing from the NHANES 2007–2016 cohort followed 2,728 adults with chronic kidney disease and found that higher De Ritis ratios were associated with higher all-cause and cardiovascular mortality. Compared with ratios <=0.98, ratios >=1.32 carried higher adjusted risk. That supports prognostic value in CKD, but it should not be copied as a universal threshold for healthy adults.

A separate 2025 multicenter analysis of 22,361 critically ill elderly patients (>=65) found a non-linear relationship between AST/ALT and 28-day mortality, with a threshold around 2.161. That ICU finding is useful for risk-stratification research, but it should not be treated as a home interpretation cutoff.

Link to Metabolic Diseases

An abnormal AST/ALT ratio has been associated with:

• Hypertension: chronic liver damage contributes to endothelial dysfunction
• Type 2 diabetes: the ratio can correlate with insulin resistance, but fasting insulin, glucose, HbA1c, triglycerides, and waist circumference give the broader metabolic picture
• Steatotic liver disease: both alcohol-associated liver disease (ALD) and metabolic dysfunction-associated steatotic liver disease (MASLD)
• Cancer: some cohorts associate higher ratios with incident cancer or poorer prognosis, but this is not a cancer screening test
• Chronic kidney disease: 2025 NHANES data link rising De Ritis ratios to cardiovascular and all-cause mortality in CKD patients

The Liver as a Longevity Hub

The liver is far more than a detoxification organ — it is the body’s metabolic control center. It manages lipid, protein, and carbohydrate metabolism, regulates blood glucose levels, synthesizes essential proteins like albumin, and metabolizes drugs and hormones. A liver that functions optimally is a prerequisite for healthy aging.

---

7 Science-Backed Strategies to Optimize Your AST/ALT Ratio

1. Reduce Visceral Fat

Why it works: Fat accumulated around the abdominal organs, particularly the liver, is the leading cause of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD). Reducing visceral fat by as little as 5–10% can normalize transaminase levels.

How to do it:

• Keep your waist circumference below 37 inches (94 cm) for men and 31.5 inches (80 cm) for women
• Favor a moderate caloric deficit (300–500 kcal/day) over crash diets
• Moderate-intensity aerobic exercise is the most effective way to reduce liver fat

What to expect: transaminases often improve when weight loss meaningfully reduces liver fat and insulin resistance; recheck labs rather than assuming a fixed timeline.

2. Drastically Limit Alcohol

Why it works: Alcohol is directly hepatotoxic, and AST is particularly sensitive to alcohol-related damage. Even consumption considered “moderate” can alter the AST/ALT ratio over time. The biological aging science on this is clear: alcohol accelerates epigenetic aging, shortens telomeres, and disrupts sleep architecture — with AST and ALT providing the most direct measurable evidence of alcohol’s cumulative cellular damage.

How to do it:

• If alcohol is driving the pattern, abstinence is the cleanest diagnostic and therapeutic trial to discuss with your clinician
• If you drink, stay within low-risk guidelines and avoid binge patterns
• Recheck AST, ALT, GGT, and MCV after a clinician-approved reduction period

What to expect: alcohol-related enzyme patterns can improve after sustained reduction or abstinence, but the timeline depends on baseline liver injury, GGT, nutrition, and fibrosis status.

3. Adopt a Liver-Protective Diet

Why it works: Certain foods support liver regeneration and reduce inflammation, while others overload the liver.

How to do it:

• Increase your intake of cruciferous vegetables (broccoli, cauliflower, cabbage), legumes, whole grains, and minimally processed foods
• Incorporate antioxidant-rich foods: berries, turmeric, green tea
• Drastically reduce added sugars and industrial fructose, which promote hepatic lipogenesis
• Favor monounsaturated fats (extra-virgin olive oil, avocado) over saturated fats

What to expect: a Mediterranean-style pattern can improve ALT and liver-fat markers, especially when it replaces added sugar, refined starch, and excess saturated fat.

4. Exercise Regularly (But Smartly)

Why it works: Physical activity improves hepatic insulin sensitivity and promotes fatty acid oxidation in the liver. However, intense exercise temporarily raises AST.

How to do it:

• 150–300 minutes per week of moderate aerobic activity (brisk walking, swimming, cycling)
• 2–3 strength training sessions per week
• Wait at least 48–72 hours after an intense workout before getting blood drawn

What to expect: exercise can reduce liver fat and improve insulin sensitivity even before major weight loss, but avoid hard training immediately before lab work.

5. Manage Medications Carefully

Why it works: Many common medications are metabolized by the liver and can elevate transaminases, altering the AST/ALT ratio.

How to do it:

• Avoid chronic acetaminophen (paracetamol) use (do not exceed 2 g/day; never combine with alcohol)
• If you take statins or other long-term medications, follow your clinician’s monitoring plan rather than stopping medication on your own
• Discuss less hepatotoxic alternatives with your doctor whenever possible
• Be cautious with herbal supplements: some marketed as “natural” are hepatotoxic

What to expect: medication-related enzyme changes often improve after the cause is changed or stopped, but only make medication changes with medical supervision.

6. Control Chronic Inflammation

Why it works: Low-grade systemic inflammation accelerates liver damage and alters the AST/ALT ratio. Chronic inflammation is also one of the primary drivers of biological aging.

How to do it:

• Maintain quality sleep (7–9 hours per night)
• Practice stress management techniques (meditation reduces inflammatory markers)
• Increase omega-3 intake through fatty fish (salmon, mackerel, sardines) 2–3 times per week
• Reduce ultra-processed foods that promote inflammation

What to expect: inflammatory markers and liver enzymes may improve when sleep, metabolic health, alcohol, and diet improve together.

7. Monitor Your Values Regularly

Why it works: The AST/ALT ratio is a dynamic indicator that reflects liver health in real time. Tracking it over time allows you to spot negative trends before they become problematic.

How to do it:

• Get a comprehensive liver panel (AST, ALT, GGT, alkaline phosphatase) at least 1–2 times per year
• Always record the AST/ALT ratio — many labs do not calculate it automatically
• Compare values over time, not just against reference ranges
• If the ratio changes direction (from <1 to >1 or vice versa), follow up with your doctor

What to expect: earlier identification of trends that enable timely follow-up.

---

How to Track and Measure the AST/ALT Ratio

Regular monitoring of liver biomarkers is one of the most powerful tools for prevention. But how do you organize the data effectively?

Key Metrics to Monitor

Metric	Tracking Zone	What It Indicates
AST	Lower-normal, interpreted with CK and recent exercise	Hepatic, muscular, and red-cell context
ALT	Lower-normal, interpreted with metabolic risk	Hepatocellular injury and liver-fat burden
AST/ALT Ratio	0.8 – 1.2	Type and progression of liver damage
GGT	< 25 U/L	Alcohol/drug-related liver damage, oxidative stress
Alkaline Phosphatase	Lab-specific range plus trend	Liver, bile duct, bone, and mineral-metabolism context

The Complete Liver Panel

For an accurate assessment, measuring AST and ALT alone is not enough. A complete panel also includes GGT, alkaline phosphatase, bilirubin, and albumin. Analyzed together, these markers provide a three-dimensional picture of liver function.

---

How SuperAge Helps You Monitor Liver Health

Keeping track of liver biomarkers over time can be complicated: lab reports pile up, values get forgotten, and trends slip through the cracks. SuperAge transforms this process.

Your Biomarkers in One Place

SuperAge lets you log and visualize blood test results over time, including AST, ALT, and other liver markers. You can see the trend of your AST/ALT ratio and instantly understand whether your values are improving or worsening.

The Link to Biological Age

The AST/ALT ratio is one of many biomarkers that contribute to determining your biological age. SuperAge integrates blood test data with information from Apple Watch (HRV, resting heart rate, physical activity) to calculate an overall biological age that truly reflects the state of your body’s health.

Personalized Trends and Insights

Instead of comparing isolated numbers, SuperAge shows you trends over time and helps you understand how your daily habits — diet, exercise, sleep — concretely affect your liver biomarkers.

---

Frequently Asked Questions

Can the AST/ALT ratio be normal even with elevated transaminases?

Yes. If both enzymes are elevated in the same proportion, the ratio can still be close to 1 (normal). That is why it is essential to evaluate both the absolute values and the ratio. Transaminases of 80/80 U/L yield a ratio of 1, but still indicate a problem.

Can exercise skew the AST/ALT ratio?

Absolutely. Intense exercise, especially strength training, can increase AST up to 4 times more than ALT for a week after the workout. To get accurate results, avoid intense training in the 48–72 hours before your blood draw.

How often should I check my AST/ALT ratio?

For most healthy adults, 1–2 times per year is sufficient. If you have risk factors (excess weight, alcohol consumption, hepatotoxic medications, family history of liver disease), every 3–6 months is more appropriate.

Is the AST/ALT ratio included in biological age calculations?

In many biological age models, the individual AST and ALT values and their ratio contribute to the overall calculation. The PhenoAge model, for example, uses albumin and alkaline phosphatase as direct components — markers closely tied to liver function.

Can I improve the AST/ALT ratio without medication?

In many metabolic or alcohol-related patterns, yes. Losing visceral fat, reducing alcohol exposure, following a liver-protective diet, and exercising regularly can improve AST, ALT, and GGT over time. However, if values remain abnormal despite lifestyle changes, it is important to rule out specific causes with your doctor.

---

Key Takeaways

• The AST/ALT ratio adds context to individual values: a ratio near 1 is often balanced, while major deviations point to patterns worth investigating
• Prevention targets are narrower than broad lab ranges: lower-normal AST and ALT can be useful goals, but targets should be personalized
• The ratio is associated with long-term risk: cohort studies link higher ratios with mortality, cancer incidence, and metabolic disease patterns, but causality is not established
• Lifestyle is the first layer: reducing visceral fat, limiting alcohol, and following a Mediterranean-style diet are major levers, but persistent abnormalities need medical workup

---

Start Monitoring Your Liver Health Today

Your blood tests contain valuable information that you are probably not leveraging. The AST/ALT ratio is just one of many biomarkers that, when tracked over time, can give you a real advantage in prevention and in slowing biological aging.

Ready to take control? Download SuperAge and start tracking your liver biomarkers alongside your biological age.

---

References

1. De Ritis F, Coltorti M, Giusti G (1957) — An enzymatic test for the diagnosis of viral hepatitis: the transaminase serum activities — First description of the AST/ALT ratio.
2. Botros M, Sikaris KA (2013) — The De Ritis Ratio: The Test of Time — Historical review and clinical validation of the ratio.
3. Chen W. et al. (2022) — Elevated AST/ALT ratio is associated with all-cause mortality and cancer incident — Journal of Clinical Laboratory Analysis community cohort of 9,946 adults.
4. Sorbi D, Boynton J, Lindor KD (1999) — The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. American Journal of Gastroenterology.
5. AAFP (2017) — Mildly Elevated Liver Transaminase Levels: Causes and Evaluation — Primary care guidance for interpreting elevated AST and ALT.
6. Scientific Reports (2025) — Association between De-Ritis ratio (AST/ALT) and mortality in patients with chronic kidney disease: a retrospective cohort study — NHANES 2007-2016 analysis of 2,728 CKD patients.
7. Scientific Reports (2025) — A non-linear association between AST/ALT ratio and 28-day mortality in critically ill elderly — Multicenter study of 22,361 patients aged 65+ with a threshold effect around 2.161.
8. Rinella ME, Lazarus JV, Ratziu V, et al. (2023) — A multisociety Delphi consensus statement on new fatty liver disease nomenclature — Replacement of NAFLD/NASH terminology with MASLD/MASH.

---

Last updated: 2026-07-07. This article is reviewed regularly to ensure accuracy.

The information provided does not replace professional medical advice. Consult your doctor before making significant changes to your lifestyle or medication regimen.